Article

Eye movement dysfunction in schizophrenia: a heritable characteristic for enhancing phenotype definition.

Clinical Science and Psychopathology Research Traing Program , University of Minnesota, MN 55455-0344l, USA.
American Journal of Medical Genetics (Impact Factor: 3.23). 02/2000; 97(1):72-6.
Source: PubMed

ABSTRACT The occurrence of ocular motor dysfunction in schizophrenia patients and their first-degree biological relatives is remarkably consistent, suggesting that abnormal smooth pursuit and saccadic oculomotion are heritable characteristics that can be used to identify gene carriers for schizophrenia. Saccadic system dysfunction probably reflects a generalized deficit in prefrontal cortical functioning, rather than a specific deficit in saccade system functioning. Although abnormal smooth pursuit has also been associated with impaired frontal functioning, it is unclear whether these two types of dysfunction arise from the same neural pathology. Therefore, deviant smooth pursuit and saccadic oculomotion may constitute unrelated factors identifying two different types of genetic risk. Alternatively, they may derive from a single risk factor that causes (a) both types of deficits to be expressed together or (b) each type to be expressed separately as pleiotropic manifestations of the underlying genotype. Although a full complement of pursuit and saccade measures has not been examined together in family studies of schizophrenia, there is obvious value in determining how these measures relate to one another in schizophrenia families and whether they can be used in combination to enhance phenotype definition to facilitate the search for schizophrenia susceptibility genes.

0 Bookmarks
 · 
42 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The relapse rate for many psychiatric disorders is staggeringly high, indicating that treatment methods combining psychotherapy with neuropharmacological interventions are not entirely effective. Therefore, in psychiatry, there is a current push to develop alternatives to psychotherapy and medication-based approaches. Cognitive deficits have gained considerable importance in the field as critical features of mental illness, and it is now believed that they might represent valid therapeutic targets. Indeed, an increase in cognitive skills has been shown to have a long-lasting, positive impact on the patients' quality of life and their clinical symptoms. We hereby present four principal arguments supporting the use of event-related potentials (ERP) that are derived from electroencephalography, which allow the identification of specific neurocognitive deficiencies in patients. These arguments could assist psychiatrists in the development of individualized, targeted therapy, as well as a follow-up and rehabilitation plan specific to each patient's deficit. Furthermore, they can be used as a tool to assess the possible benefits of combination therapy, consisting of medication, psychotherapy, and "ERP-oriented cognitive rehabilitation". Using this strategy, specific cognitive interventions could be planned based on each patient's needs, for an "individualized" or "personalized" therapy, which may have the potential to reduce relapse rates for many psychiatric disorders. The implementation of such a combined approach would require intense collaboration between psychiatry departments, clinical neurophysiology laboratories, and neuropsychological rehabilitation centers.
    Neuropsychiatric Disease and Treatment 11/2013; 9:1835-1845. DOI:10.2147/NDT.S53687 · 2.15 Impact Factor
    This article is viewable in ResearchGate's enriched format
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Republic of Palau in the western Pacific has one of the highest rates of schizophrenia diagnoses in the world today. The expression of schizophrenia in Palau and greater Micronesia is also extraordinarily gendered, with rates of affliction approximately two times higher among males. This study uses contemporary clinical diagnostic and research tools to consider and reject the hypotheses that schizophrenia in Palau has a unique diagnostic profile, that it has a unique bio-behavioral expression, and that it is a consequence of "development" manifest in the introduction and use of psychoactive drugs. These results are used to critique an assumption that has emerged from previous cross-cultural research - that the expression of schizophrenia is necessarily more benign in "developing" settings and to suggest that aspects of historical and contemporary social practices may contribute to a gender imbalance in the expression of symptoms of schizophrenia in this Pacific Island nation.
    Current Anthropology 04/2007; 48(2):189-213. DOI:10.1086/510474 · 2.93 Impact Factor